October 3, 2022
When most people think of civil engineering, images of construction sites, bridges and tunnels will likely come to mind. However, a recent collaboration between Arizona State University and Mayo Clinic is placing civil engineers in a new light.
There is a huge world out there where engineers can use their skills in areas that are traditionally not associated with civil engineering, says Subramaniam Subby Rajan, a civil engineering professor in the Ira A. Fulton Schools of Engineering at ASU.
Putting that concept to the test, Rajan has spearheaded a number of projects in the School of Sustainable Engineering and the Built Environment, part of the Fulton Schools, with private companies such as Honeywell and Raytheon and government organizations such as the Federal Aviation Administration and NASA. He has aided in the materials testing of everything from jet engines to bulletproof vests efforts that have not only expanded his knowledge of civil engineering, but also that of his students and research assistants who get to participate in the studies as well.
If you ask a person on the street or even a practicing civil engineer whether civil engineering skills can be used in answering questions dealing with bone fractures, the answer will inevitably be 'no'; there is not a connection between the two. However, there are a lot of connections, Rajan says.
In his latest research project, Rajan is using his civil engineering expertise to help forensic researchers draw more accurate conclusions about the impact of trauma made on the human body.
Video by Steve Filmer/ASU Media Relations
Subramaniam Subby Rajan
With a long track record of applying civil engineering mechanics to diverse research projects, Rajan was contacted by researchers at Mayo Clinic in Arizona. The team is actively working on a project that could redefine the process for identifying trauma made to human remains. More specifically, the research could allow forensic anthropologists to determine the time at which blunt-force trauma may have occurred to a human body with greater precision and, ultimately, if the trauma played a role in a person's death.
This work is important to forensic scientists because knowing whether a fracture occurred perimortem at or around the time of death versus postmortem can give us important information about the cause and manner of death with crime scene investigations, says Natalie Langley, a consultant in the Department of Laboratory Medicine and Pathology at Mayo Clinic in Arizona and president of the American Board of Forensic Anthropology.
The collaborative team at Mayo Clinic also includes researchers from the Center for Regenerative Medicine in Arizona, the Biomaterials and Histomorphometry Core Laboratory at Mayo Clinic Rochester, Mayo Clinic postdoctoral research fellow Jessica Skinner and ASU's Barrett, The Honors College graduate intern Yuktha Shanavas.
Langley explains that femur bones are sourced from males between the ages of 50 and 80 who donated their bodies to scientific research. Those demographic variables were chosen to control for sex- and age-related compositional differences in bone. The bones are then heated at controlled temperature and humidity for varying amounts of time to simulate the loss of elasticity that bones experience during the postmortem interval.
Bone is an elastic material, and it maintains elasticity for some time after death, Langley says. By heating the bone, we are able to replicate longer periods of time after death that commonly lead to a bone losing some elasticity, leaving different fracture patterns than if it were broken while still elastic.
A layer of spray paint is also applied to the surface of the bones so high-speed cameras can detect deformation and surface strain that occur during the impact testing.
Donated femur bones are coated in a black-and-white speckled spray paint that allows high-speed cameras to capture the deformations on the surface of the sample during fracture testing. Photo by Monica Williams/ASU
Langley says her team needed help minimizing the unknowns in their research.
I contacted ASU initially because we needed an impact tester to induce fractures in a controlled manner, she says.
Rajans team and Mayo Clinic researchers created a special apparatus to hold a fragment of femur bone to allow for an impactor to drop at a controlled and monitored rate.
These are impacts that are strong enough to break a bone, but they are not as high velocity as a gunshot wound, Langley says. We even take it one step further and use high-speed photography to measure, or track, the movement of the bone during the fracture process.
This allows her team to consider what forces are being distributed across the bone.
Once the bone is fractured, it is handed back over to Langley and her team for a thorough review and documentation of the fracture characteristics.
One of the things we look at is the pattern of the fracture, Langley says. Fractures that occur at or around the time of death have a certain appearance; and those that occur much longer after death, when the bone is not as elastic, have a different appearance.
We captured 5,000 frames per second and were able to tell where the weight struck the bone and where the cracks were propagating in the bone, says Ashutosh Maurya, a graduate research associate who volunteered to participate in the bone testing.
Maurya is completing his doctorate in civil, sustainable and environmental engineering in the Fulton Schools. Despite the bone testing research having a different focus from his dissertation work, he felt it was a great opportunity to expand his skills as he explores impact dynamics problems connected to aircraft structures.
If you look at almost any research, you will see people from different areas working together, Maurya says. This will definitely help me in my future career as I collaborate with non-engineering background professionals and manage projects across disciplines.
Ashutosh Maurya, a doctoral student of civil, sustainable and environmental engineering, volunteered to participate in the collaboration with Mayo Clinic in hopes of expanding his experience working with individuals in different research fields. Photo by Monica Williams/ASU
It is a philosophy Mauryas mentor Rajan has tried to instill in all of the students that pass through his classroom.
It's only when you start looking at the fundamental tools that are used across all these different problems, that you find there are a lot of commonalities, Rajan says. For this specific project, we are able to make an impact beyond what is commonly expected of civil engineers.
In the coming months, Langley and her team will be compiling data from the fracture testing, tracking formations and markings left in the bones at different intervals of drying. The results will then be used to create a new standard for determining when trauma was inflicted on a crime victim.
Working with Rajan and his team allowed us to think outside of the box of our own work, Langley says. Their knowledge in controlling the variables with forcefully creating fractures gives validity to our work, ultimately changing the process for solving crimes and giving closure to families.
Top photo:Natalie Langley, a consultant in the Department of Laboratory Medicine and Pathology at Mayo Clinic in Arizona, applies fingerprint powder to a fractured bone to help see fracture surface markings left by an impact. These markings are then documented to help create a new set of criteria for determining the timing of fracture events (e.g., perimortem versus postmortem). Photo by Monica Williams/ASU
Follow this link:
Fracturing bones and traditional views of civil engineering - ASU News Now
- Regenerative medicine UKRI - UK Research and Innovation - December 10th, 2023
- What Is Regenerative Medicine? | Goals and Applications | ISCRM - December 2nd, 2023
- What Is Regenerative Medicine? | Mass General Brigham - December 2nd, 2023
- Advancing Safe and Effective Regenerative Medicine Products - March 20th, 2023
- Can This Companys Research Help Transform Regenerative Medicine As Its ... - December 18th, 2022
- Regenerative Medicine in Pharma Market Size, Share and Trends Analysis by Region, Drug Class, Route of Administration, and Segment Forecast, 2022-2027... - December 10th, 2022
- Stem Cells Applications in Regenerative Medicine and Disease ... - November 16th, 2022
- Neuroregeneration - Center for Regenerative Biotherapeutics - Mayo ... - November 16th, 2022
- Journal of Immunology and Regenerative Medicine - ScienceDirect - November 16th, 2022
- A Look At Some Of The Companies Innovating In the Cutting-Edge ... - November 16th, 2022
- Regenerative Medicine Advanced Therapy Designation | FDA - October 29th, 2022
- Packing More Punch for Regenerative Medicine and Cell and Gene Therapies - Inside Precision Medicine - October 29th, 2022
- Brush Up: Tissue Engineering and Regenerative Medicine - The Scientist - October 21st, 2022
- The Alliance for Regenerative Medicine Announces Election of 2023 Officers, Executive Committee, and Board of Directors - GlobeNewswire - October 13th, 2022
- Husband and Wife Team Bring Regenerative Medicine Clinic to Jackson - Franchising.com - October 13th, 2022
- Hundreds run for regenerative medicine research at the 2022 TCS London Marathon - British Heart Foundation - October 13th, 2022
- Frequency Therapeutics Completes Enrollment of Phase 2b Study of FX-322 for the Treatment of Sensorineural Hearing Loss - Yahoo Finance - October 13th, 2022
- SANUWAVE's Energy First Technology to be Featured in 3 Clinical Posters at Upcoming 2022 Fall Symposium on Advanced Wound Care (SAWC) -... - October 13th, 2022
- 3D Bioprinting Market Size to Touch Valuation of $1.5 Billion by 2028 | Inkjet Technology Generates More than 38% Revenue of Bioprinting Market -... - October 13th, 2022
- QC Kinetix (Columbia) Offers Regenerative Medicine Treatments to Treat Different Types of Physical Pain and Injuries - Yahoo Finance - October 4th, 2022
- Astellas and Pantherna Enter into a New Technology Evaluation Agreement for Research with Expanded Target Organ to Generate mRNA-Based Regenerative... - October 4th, 2022
- Company / An Advance In Vaginal Rejuvenation, Regenerative Medicine And Aesthetic Gynecology - World Nation News - October 4th, 2022
- Performance Rehabilitation and Regenerative Medicine's Dr. Joseph Mejia honored as a Castle Connolly Top Doctor - Jersey's Best - October 4th, 2022
- Teijin, J-TEC, Mitsui Fudosan, and NCC to create a new platform for regenerative medicine innovation - The Worldfolio - October 4th, 2022
- Cell Regeneration Medicine Market to be valued at US$ 34.3 Bn by the end of 2022 | FMI Research - PharmiWeb.com - October 4th, 2022
- Enlivex to Present at the 4th Macrophage-Directed Therapies Summit - Yahoo Finance - October 4th, 2022
- BioMarin Resubmits Biologics License Application (BLA) for Valoctocogene Roxaparvovec AAV Gene Therapy for Severe Hemophilia A to the FDA - PR... - October 4th, 2022
- Organ on a Chip Market - Focus on Products and Technologies - Distribution by Type of Product, Application Area, Purpose, and Key Geographical Regions... - October 4th, 2022
- QC Kinetix (Riverside Parkway) Offers Regenerative Medicine Treatments to Treat Pain and Injuries in Tulsa, OK - Yahoo Finance - September 25th, 2022
- Reprogramming pig cells leads way for new regenerative therapies - National Hog Farmer - September 25th, 2022
- Research Roundup: Regenerative Potential, Long COVID Insights, Immuno-Oncology and More - BioSpace - September 25th, 2022
- Dr. Batcheller's Wellness and Esthetics, Mecca for Regenerative Medicine and Esthetics - Digital Journal - September 25th, 2022
- Organicell Regenerative Medicine, Inc. Announces Expansion of Management Team - Yahoo Finance - September 25th, 2022
- Pfizer and Sangamo Therapeutics Announce Phase 3 Trial of Investigational Gene Therapy for Hemophilia A Has Re-Opened Recruitment - Pfizer - September 25th, 2022
- Neurona Therapeutics Presents Clinical Case Study from First Human Trial of Regenerative Cell Therapy, NRTX-1001, in Adults with Drug-Resistant Focal... - September 25th, 2022
- Center for Breakthrough Medicines (CBM) and jCyte Announce Strategic Partnership to Manufacture jCyte's Innovative Cell Therapy for Treatment of... - September 25th, 2022
- 2022 UK Equine Research Hall of Fame Inductees Announced The Horse - TheHorse.com - September 25th, 2022
- Science on the go: Catch the Veterinary Vertex podcast - American Veterinary Medical Association - September 25th, 2022
- Advanced robotics to address the translational gap in tendon engineering - EurekAlert - September 25th, 2022
- Russ Olsen Makes Multi-Million Dollar Pledge in support of the Robert Morris University Library - Robert Morris University - September 25th, 2022
- Humacyte Expands Board of Directors and Leadership Team with New Appointments - Yahoo Finance - September 25th, 2022
- First time in India: Stem cell therapy to treat knee osteoarthritis - Moneycontrol - September 25th, 2022
- George Church: Learn from COVID and fast-track therapies that reverse aging - Longevity.Technology - September 25th, 2022
- EpiBone CEO and Co-Founder Dr. Nina Tandon Selected to Participate in White House Summit - PR Web - September 25th, 2022
- Krystal Biotech Receives Positive Opinion from EMA Pediatric Committee on the Pediatric Investigation Plan for B-VEC for the treatment of Dystrophic... - September 25th, 2022
- Humacyte Announces Presentations by Ukrainian Surgeons on Use of the Human Acellular Vessel to Treat Wartime Vascular Trauma at the European Society... - September 25th, 2022
- Fertility Supplements And Vitamins For Women: What You Need To Know - Forbes - September 25th, 2022
- CIRM awards UCI $2.7 million to create regenerative medicine training program - UCI News - September 16th, 2022
- Regenerative Medicine Hub at W-S Innovation Quarter keeps growing with new addition - WRAL TechWire - September 16th, 2022
- QC Kinetix (Chandler): The Future of Regenerative Medicine in Arizona - Digital Journal - September 16th, 2022
- Platelet-Rich Plasma: A Promising Regenerative Therapy in Gynecological Disorders - Cureus - September 16th, 2022
- 4 to be inducted into UK Equine Research Hall of Fame - WTVQ - September 16th, 2022
- FACT SHEET: The United States Announces New Investments and Resources to Advance President Bidens National Biotechnology and Biomanufacturing... - September 16th, 2022
- AVITA Medical Achieves Positive Topline Pivotal Trial Results for Treatment of Stable Vitiligo Using the RECELL System - Yahoo Finance - September 16th, 2022
- Cell Culture Media Market worth $10.3 billion by 2026 - Exclusive Report by MarketsandMarkets - GlobeNewswire - September 16th, 2022
- Following some big FDA wins, Carmell Therapeutics plans to go public. Here's why - Technical.ly - September 16th, 2022
- Pharmaceutical Drug Delivery Market is expected to generate a revenue of USD 2,583 Billion by 2030, Globally, at 6.6% CAGR: Verified Market Research -... - September 16th, 2022
- Capstan Therapeutics Launches with $165 Million to Deliver on the Clinical Promise of Precise In Vivo Cell Engineering - Business Wire - September 16th, 2022
- Children's Health will fund pediatric unit at the Texas Health and Human Services Commission UT Southwestern Medical Center psychiatric hospital - UT... - September 16th, 2022
- Cell Line Development Market Projected to Experience a CAGR of 5% from 2022 to 2032, value worth US$ 7.66 Billion | Future Market Insights, Inc. -... - September 16th, 2022
- UB researchers identify new model of cerebral cortex development linked to reelin protein expression - EurekAlert - September 16th, 2022
- NYC Dermatologist, Dr. Julie Russak, launches first Anti-Aging Wellness Program of its kind in the U.S. - PR Web - September 16th, 2022
- About Regenerative Medicine - Center for Regenerative Biotherapeutics ... - September 8th, 2022
- Global Exosome Market Report 2022: Integration into Fields of Liquid Biopsy, Precision Medicine, and Regenerative Medicine Driving Growth -... - September 8th, 2022
- Addressing Diversity Barriers to Regenerative Medicine Free Press of Jacksonville - Jacksonville Free Press - September 8th, 2022
- Looking to buy Mesoblast shares? Here's the latest on where the ASX biotech is at with the FDA - The Motley Fool Australia - September 8th, 2022
- Sernova Announces the Appointment of Daniel Mahony, Ph.D. to its Board of Directors - GlobeNewswire - September 8th, 2022
- 7.5 Million Granted to Collaborative PROTO Project led by Charit to Study Pluri's PLX-PAD Cells for Osteoarthritis Treatment - GlobeNewswire - September 8th, 2022
- Regenerative Medicine Market to Garner Bursting Revenues [+USD 27.29 Billion] with Top Growing Companies During 2022-2029 - eTurboNews | eTN - August 30th, 2022
- ElevateBio Partners with the California Institute for Regenerative Medicine to Accelerate the Development of Regenerative Medicines - Business Wire - August 30th, 2022
- Global Cell Therapy Market to Reach a Capital Expenditure of USD 10.23 billion in 2021 - eTurboNews | eTN - August 30th, 2022
- Therapeutic Solutions International Develops Gene Silencing Therapy for Acute Respiratory Distress Syndrome - BioSpace - August 30th, 2022
- How Astrocytes May Be Able to Help With Brain Repair - Best Health Magazine - August 30th, 2022
- Applied StemCell Announces the Expansion of its cGMP Manufacturing Facility to Support Cell and Gene Therapy - Business Wire - August 30th, 2022
- Scientists just bypassed millions of years worth of evolution in mice - Inverse - August 30th, 2022
- NIAMS Update, Issue 4, 2022 | NIAMS - National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) - August 30th, 2022
- Heart Association fellowship to support research - Binghamton - August 30th, 2022
- Climate change is making the new school year harder in all kinds of ways - Salon - August 30th, 2022
- Global Biomaterials Market to Reach Value of $372.7 Billion by 2028 | Demand For Biomaterials in the Healthcare Industry will Grow by 53% Over the... - August 30th, 2022
- Dosing of Novel Autologous CAR T Cells and Nivolumab Begins in cHL Study - Targeted Oncology - August 22nd, 2022